SCHEMBL20005677

SCHEMBL20005677

Cc1ccc(OCCCOc2ccccc2Cl)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 8/20 0.71
MAPT P10636 6/20 0.71
TDP1 Q9NUW8 1/20 0.71
RAB9A P51151 4/20 0.63
HPGD P15428 4/20 0.63
NPC1 O15118 3/20 0.63
CYP1A2 P05177 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
DRD2 P14416 6/20 0.58
DRD4 P21917 6/20 0.58
DRD3 P35462 6/20 0.58
ATM Q13315 2/20 0.56
PPARG P37231 2/20 0.53
PPARD Q03181 1/20 0.53
PPARA Q07869 1/20 0.53
CISD1 Q9NZ45 1/20 0.51
KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5290069 0.95 L3MBTL1 (0.69) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL10597748 0.81 L3MBTL1 (0.90) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL9117427 0.81 L3MBTL1 (0.90) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL1592400 0.80 DRD2 (0.72) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL30167630 0.80 L3MBTL1 (0.66) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL3794754 0.80 L3MBTL1 (0.66) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL14586645 0.79 DRD2 (0.72) L3MBTL1RAB9AHPGDNPC1DRD2
SCHEMBL5929468 0.79 DRD2 (0.68) L3MBTL1SMN1; SMN2DRD2DRD4DRD3
SCHEMBL17261374 0.78 L3MBTL1 (0.64) L3MBTL1MAPTTDP1RAB9AHPGD
SCHEMBL91268 0.78 L3MBTL1 (0.69) L3MBTL1MAPTTDP1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 L3MBTL1 805/4885MAPT 3938/4885TDP1 2209/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 L3MBTL1 805/4885MAPT 3938/4885TDP1 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.